{"id":"W2971213137","doi":"10.1016/j.clml.2019.07.116","title":"Clinical Benefit of Glasdegib Plus Low-Dose Cytarabine in Patients with De Novo and Secondary Acute Myeloid Leukemia: Long-Term Analysis of a Phase 2 Randomized Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Cytarabine; Medicine; Myeloid leukemia; Internal medicine; Oncology; Randomized controlled trial; Chemotherapy; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001478568,0.001477436,0.002876713,0.0003691599,0.0004171366,0.001426777,0.0008287809,0.001343778,0.002911328],"category_scores_gemma":[0.001111396,0.0004686052,0.002015711,0.0005131094,0.001158868,0.001333788,0.0004432056,0.003585252,0.0006547992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001118468,"about_ca_system_score_gemma":0.001071693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009217994,"about_ca_topic_score_gemma":0.002717245,"domain_scores_codex":[0.9994117,0.0003099526,0.00002778957,0.0001002584,0.00003655638,0.0001138128],"domain_scores_gemma":[0.9991974,0.0001707298,0.0001628548,0.00006376081,0.00003841228,0.0003669073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9584135,0.003522692,0.001915401,0.0003608695,0.001516432,0.00004746893,0.00005077673,0.0008353759,0.003999199,0.0001198129,0.001047178,0.02817131],"study_design_scores_gemma":[0.899141,0.09030423,0.006807731,0.00003825045,0.0008769914,0.00007632219,0.00004693534,0.0007135696,0.0006351766,0.0002895984,0.001043092,0.00002709181],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903553,0.005676767,0.0003910344,0.0008295503,0.0002926204,0.0005694414,0.0006763028,0.00007492858,0.001134093],"genre_scores_gemma":[0.992262,0.002317781,0.0006513388,0.000966183,0.000269787,0.0006508613,0.001311907,0.00002109579,0.001549131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002911328,"threshold_uncertainty_score":0.009739339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01257345691671655,"score_gpt":0.3092272931367638,"score_spread":0.2966538362200472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}